Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 3/2010

01-03-2010 | Letter to Editor

Anti-cyclic citrulline peptide antibody in non-tuberculous mycobacteria sera: a negative association

Authors: Mi-Kyoung Lim, Tae Sun Shim, Dong-Hyuk Sheen, Dong-Jib Na, Sun Seek Min, Seung-Cheol Shim

Published in: Clinical Rheumatology | Issue 3/2010

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Guedes-Barbosa LS, Mangueira C, Scheinberg M (2008) Anticitrulline peptide antibodies (CCP3) in leprosy sera: a negative association. Clin Rheumatol 27:515–516CrossRefPubMed
2.
Lim MK, Sheen DH, Lee YJ, Mun YR, Park M, Shim SC (2009) Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection. J Rheumatol 36:712–716CrossRefPubMed
3.
Liu X, Jia R, Zhao J, Li Z, Mori S, Naito H, Ohtani S, Yamanaka T, Sugimoto M (2009) The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for rheumatoid arthritis in patients with active lung tuberculosis. J Rheumatol 36:1136–1142CrossRefPubMed
4.
Mori S, Naito H, Ohtani S, Yamanaka T, Sugimoto M (2009) Diagnostic utility of anti-cyclic citrullinated peptide antibodies for rheumatoid arthritis in patients with active lung tuberculosis. Clin Rheumatol 28:277–283CrossRefPubMed
5.
Elkayam O, Segal R, Lidgi M, Caspi D (2006) Positive anti-cyclic citrullinated proteins and rheumatoid factor during active lung tuberculosis. Ann Rheum Dis 65:1110–1112CrossRefPubMed
6.
McGrath EE, McCabe J, Anderson PB (2008) Guidelines on the diagnosis and treatment of pulmonary non-tuberculous mycobacteria infection. Int J Clin Pract 62:1947–1955CrossRefPubMed
7.
Lee H, Park HJ, Cho SN, Bai GH, Kim SJ (2000) Species identification of mycobacteria by PCR-restriction fragment length polymorphism of the rpoB gene. J Clin Microbiol 38:2966–2971PubMed
8.
Piersimoni C, Scarparo C (2008) Pulmonary infections associated with non-tuberculous mycobacteria in immunocompetent patients. Lancet Infect Dis 8:323–334CrossRefPubMed
Metadata
Title
Anti-cyclic citrulline peptide antibody in non-tuberculous mycobacteria sera: a negative association
Authors
Mi-Kyoung Lim
Tae Sun Shim
Dong-Hyuk Sheen
Dong-Jib Na
Sun Seek Min
Seung-Cheol Shim
Publication date
01-03-2010
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 3/2010
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1327-4

Other articles of this Issue 3/2010

Clinical Rheumatology 3/2010 Go to the issue

Original Article

Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis

Original Article

The prognostic factors of systemic sclerosis for survival among Koreans

Original Article

Capillary dimension measured by computer-based digitalized image correlated with plasma endothelin-1 levels in patients with systemic sclerosis

Original Article

Anti-agalactosyl IgG antibodies in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis

Original Article

The effect of anti-TNF agent on oxidation status in patients with ankylosing spondylitis

Brief Report

Mycophenolate mofetil in Takayasu’s arteritis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits